Landscapes / Companies
Longbio Pharma not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 3 in all
Trials
9 active
14 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 28 Feb 2027Phase 2 trial completes | |||
| Next date | 28 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Chronic Spontaneous Urticaria, Allergic Diseases and 7 more | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Dec 2027Phase 2 trial completes | |||
| Next date | 30 Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | PNH - Paroxysmal Nocturnal Hemoglobinuria, Paroxysmal Nocturnal Hemoglobinuria and 2 more | ||||
| Open drug page | |||||
About
- No active trial
- LP-001
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021